Awaking Blood Pressure Surge and Progression to Microalbuminuria in Type 2 Normotensive Diabetic Patients
Table 2
Clinical characteristics according to the development of microalbuminuria at baseline and the last follow-up ().
Baseline
Follow-up
NA
MA
NA
MA
102
275
102
275
Age (years)
50 ± 6
51 ± 6
0.466
57 ± 6
55 ± 7
0.008
Gender (m/f)
144/131
50/52
0.565
144/131
50/52
0.565
BMI (kg/m2)
29.8 ± 2.0
30.0 ± 2.2
0.322
29.9 ± 2.0
29.4 ±2.0
0.016
HbA1c (%)
9.4 ± 1.3
9.5 ± 1.4
0.469
7.2 ± 1.0
7.4 ± 0.8
0.134
Heart rate
77 ± 9
76 ± 9
0.388
79 ± 10
78 ± 11
0.597
Mean systolic BP (mmHg)
122 ± 8
123 ± 10
0.053
126 ± 10
125 ± 11
0.707
Mean diastolic BP (mmHg)
79 ± 7
78 ± 6
0.230
79 ± 11
79 ± 8
0.951
MBSP (mmHg)
10.8 ± 1.5
10.9 ± 1.4
0.721
11.7 ± 2.2
35.3 ± 9.2
<0.001
Urinary albumin excretion (mg/24 hours)
13.3 ± 3.4
13.8 ± 3.4
0.204
19.9 ± 22.6
109 ± 38.4
<0.001
: comparison between NA and MA performed separately at baseline and at the last follow-up. : NA at baseline versus follow-up; : MA at baseline versus MA at follow-up; MA: microalbuminuric; NA: normoalbuminuric.
